Infectious Disease Models
TICRO utilizes a robust, small animal platform comprised of mice, ferrets, and hamsters, to provide compelling in vivo research solutions.
Our established preclinical infectious disease models enable researchers to screen high numbers of candidates at relatively low cost using a large number of reagents, diagnostic assays, and a variety of translational model species.
TICRO has successfully established and validated these models of infectious disease for the purpose of better understanding host-pathogen interactions and to evaluate candidate therapeutics. Moreover, TICRO maintains a library of > 20 pathogens implicated in human health and encompassing diseases relevant to the study of respiratory, enteric, ESKAPE, and parasitic infections. TICRO has the expertise, experience, and facilities to work with pathogens that require specialized housing and biosecurity requirements. These pathogens can be studied in a variety of inbred, congenic, transgenic and mutant mouse strains as well as in ferrets (e.g. influenza) and hamsters (e.g. SARS-CoV-2).
A list of our current offering of model pathogens is provided below. Please contact us for additional information or regarding the need for model development.
Bacteria
Mycobacterium tuberculosis
Streptococcus pneumonia
Pseudomonas aeruginosa
Klebsiella pneumoniae
Campylobacter jejuni
Citrobacter rodentium
Escherichia coli
Listeria monocytogenes
Salmonella
Sphingomonas
Yersinia enterocolitica
Yersinia pseudotuberculosis
Borrelia burgdorferi
Staphylococcus aureus
Virus
Influenza virus
Lymphocytic choriomeningitis virus
Murine Gamma Herpes virus
Flaviviruses
Coronavirus
Parasite
Heligomosomoides polygyrus
Toxoplasma gondii
Trichuris muris